Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ |
| Upstream (Parents) |
|---|
| (<<) LOC100126583///LOC652494///IGHV4-31///IGHM///IGHG3///IGHG2///IGHG1///IGHA2///IGHA1///IGH@ → IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ |
| (<<) LOC100126583///IGHV4-31///IGHV@///IGHM///IGHG3///IGHG2///IGHG1///IGHD///IGHA2///IGHA1///IGH@ → IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ |
| (<<) IGKV1OR2-118 → IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ |
| Downstream (Children) |
|---|
| IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ → LOC652494///IGHM///IGHG3///IGHG1///IGHA1 (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ → LOC100132941///LOC647224///IGHV3OR16-6 (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ → IGLV6-57 (>>) |
| IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA2///IGHA1///IGH@ → MAST1 (>>) |
